News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
Psilocybin Decreases Depression and Anxiety in Some Cancer Patients
Ben Andrew Henry | Dec 2, 2016
In a pair of clinical studies of psilocybin, the active ingredient in magic mushrooms, participants reported positive changes to their moods and outlooks.
Neurometabolic Disorders Could Contribute to Depression
Ben Andrew Henry | Nov 1, 2016
Impairments in the production of neurotransmitters may lead to depression in some patients, preliminary results show, opening new avenues for research.
Pooling Consumer Genetic Data, Researchers ID Links to Depression
Alison F. Takemura | Aug 2, 2016
Access to data from thousands of genotyping customers helped scientists detect novel associations with the disorder across the genome.
“Magic” Mushroom Compound Eases Depression
Tanya Lewis | May 17, 2016
Psilocybin led to an improvement in symptoms for treatment-resistant patients, according to a small study.
Zooming In on an Antidepressant Target
Ruth Williams | Apr 6, 2016
Structural studies reveal how SSRI drugs bind to the human serotonin transporter.
A Genetic Root to Seasonal Affective Disorder
Bob Grant | Feb 23, 2016
Researchers have identified a gene that ties sleeping patterns to the winter blues experienced by many people living at extreme northern and southern latitudes.
Antidepressant Exerts Epigenetic Changes
Anna Azvolinsky | Nov 25, 2015
Molecular markers could aid researchers’ assessment of patient response to the drug.
Amanda B. Keener | Sep 1, 2015
Researchers explore the benefits of hearing loss and impairment.
Genetic Variants Linked to Depression
Amanda B. Keener | Jul 20, 2015
Researchers link variations in two genes to cases of major depressive disorder in two large cohorts.
Magic Mushroom Dreams
Jef Akst | Jul 3, 2014
A psychedelic compound in hallucinogenic mushrooms triggers brain activity characteristic of dream states.